Systemic transforming growth factor-beta in patients with bone marrow fibrosis - Pathophysiological implications

American Journal of Hematology

Volumn 59, Issue 2, 1998, Pages 133-142

  Rameshwar, Pranela ^a   Chang, Victor T ^a,b   Thacker, Usha F ^a   Gascón, Pedro ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Basic fibroblast growth factor; Bone marrow; Fibrosis; Myelofibrosis; Transforming growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MONOCYTE; MYELOFIBROSIS; MYELOPHTHISIC ANEMIA; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADULT; AGED; BLOOD PLATELETS; BONE MARROW CELLS; BONE MARROW EXAMINATION; CELL DEGRANULATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; PROTEIN ISOFORMS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031667526     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199810)59:2<133::AID-AJH6>3.0.CO;2-Z     Document Type: Article

References (56)

1. McCarthy DM: Fibrosis of the bone marrow: Content and causes. Br J Haematol 59:1-7, 1985.
2. Reilly JT: Pathogenesis of idiopathic myelofibrosis: Role of growth factors. J Clin Pathol 45:461-464, 1992.
3. Tefferi A, Silverstein MN: Current perspective in agnogenic myeloid metaplasia. Leuk Lymphoma 22:169-171, 1996.
4. Loewy G, Mathew A, Distenfel A: Skin manifestation of agnogenic myeloid metaplasia. Am J Hematol 45:167-170, 1994.
5. Cook G, Sharp RA: Spinal cord compression due to extramedullary haemopoiesis in myelofibrosis. J Clin Pathol 47:464-465, 1994.
6. Charbord P: Increased vascularity of bone marrow in myelofibrosis. Br J Haematol 62:595-596, 1986.
7. Golde DW, Hockking WG, Quan SG, Sparkes RS, Gale RP: Origin of human bone marrow fibroblasts. Br J Haematol 144:183-187, 1980.
8. Jacobson RJ, Salo A, Fialkow PJ: Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189-194, 1978.
9. Greenberg BR, Woo L, Veomett IC, Payne CM, Ahmann FR: Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. Br J Haematol 66:487-490, 1987.
10. Spivak JL, Bender BS, Quinn TC: Hematologic abnormalities in AIDS. Am J Med 77:224-228, 1984.
11. Kaelin WG, Spivak JL: Systemic lupus erythematosus and myelofibrosis. Am J Med 81:935-938, 1986.
12. Taube T, Franssila K, Risteli L, Risteli J, Elomaa I: Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen. Br J Haematol 82:32-37, 1992.
13. Takada M, Umeda M, Shikoshi K, Shirai T: IgG lambda-type multiple myeloma associated with myelofibrosis accompanied by thrombocytosis. Jpn J Clin Hematol 32:1001-1005, 1991.
14. Buschle M, Janssen JWG, Drexler H, Lyons J, Anger B, Bartram CR: Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: Clonal analysis of a case characterized by a N-ras gene mutation. Leukemia 2:658-660, 1988.
15. Wang JC, Lang HD, Lichter S, Weinstein M, Benn P: Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol 80:184-188, 1992.
16. Kreipe H, Jacquet K, Feigner J, Radzum HJ, Parwaresch MR: Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood 78:1814-1817, 1991.
17. Price CM, Kanfer EJ, Colman SM, Westwood N, Barrett AJ, Greaves MF: Simultaneous genotypic and immunophenotypic analysis of interphase cells using dual-color fluorescence: A demonstration of lineage involvement in polycythemia vera. Blood 80:1033-1038, 1992.
18. 1-positive chronic myelogenous leukemia. Blood 51:1039-1044, 1978.
19. Van Slyck FJ, Weiss L, Dully M: Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood 36:729-735, 1970.
20. Nowell PC, Finan JB. Cytogenetics of acute and chronic myelofibrosis. Virchows Archives B: Cell Pathol 1978: 29: 45-50.
21. Sato Y, Sada T, Suda J, Ohsaka A, Kubota K, Saito M, Miura Y: Multilineage expression of haematopoietic precursors with an abnormal clone in idiopathic myelofibrosis. Br J Haematol 64:657-667, 1986.
22. Hasselbalch H, Jans H, Nielsen PL: A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: Evidence of an autoimmune pathogenesis. Am J Hematol 25: 225-229, 1987.
23. Cappio FC, Vigliani R, Novarino A, Camussi G, Campana D, Gavosto F: Idiopathic myelofibrosis: A possible role for immune complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 49:17-21, 1981.
24. Groopman JE: The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92:857→858, 1980.
25. Titius BR, Thiele J, Schaefer H, Kreipe H, Fischer R: Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Acta Haematol 91:144-149, 1994.
26. Martyré MC: TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma 20: 39-44, 1995.
27. Rameshwar P, Denny T, Stein D, Gascón P: Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for IL-1 and TGF-β. J Immunol 153:2819-2830, 1994.
28. Tefferi A, Silverstein MN: Agnogenic myeloid metaplasia. Cancer Invest 15:177-179, 1997.
29. Gilbert HS, Praloran V, Stanley ER: Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: Association with myeloid metaplasia and peripheral bone marrow extension. Blood 74:1231-1234, 1989.
30. Rameshwar P, Chang VT, Gascón P: Implication of CD44 in adhesion-mediated overproduction of TGF-β and IL-1 in monocytes from patients with bone marrow fibrosis. Br J Hematol 93:22-29, 1996.
31. Gleizes P-E, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB: TGF-β latency: Biological significance and mechanisms of activation. Stem Cells 15:190, 1997.
32. Newman MJ: Transforming growth factor beta and the cell surface in tumor progression. Cancer Metastasis Rev 12:34-49, 1993.
33. Hughes D, Buckley PJ: Idiopathic retroperitoneal fibrosis is a macrophage-rich process. Implications for its pathogenesis and treatment. Am J Surg Pathol 17:482-490, 1993.
34. Lawrence DA: Identification and activation of latent transforming growth factor β. Methods Enzymol 198:327-336, 1991.
35. Rameshwar P, Gascon P: Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 88:98-106, 1996.
36. Glantz AS: Primer of Biostatistics. New York: McGraw-Hill, 1992:100-105.
37. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL: Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592-1598, 1993.
38. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994.
39. Wallick SC, Gold LI, Palladino MA: Transforming growth factor β (TGF-β). In Roitt M, Delves PJ, eds. Encyclopedia of Immunology, Volume III. New York: Academic Press, 1992, pp 1498-1502.
40. Levine JH, Moses HL, Gold LI, Nanney LB: Spatial and temporal patterns of immunoreactive transforming growth factor β1, β2, and β3 during excisional wound repair. Am J Pathol 1993: 143:368-380, 1993.
41. Gospodarowicz D, Schweigerer L, Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95-114, 1987.
42. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86:356-361, 1994.
43. Gabrilove JL, Wong G, Bollenbacher E, White K, Kojima S, Wilson EL: Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-beta 1 on human myeloid progenitor cells. Blood 81:909-915, 1993.
44. Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R: Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 82:430-435, 1993.
45. Le Bousse-Kerdiles M-C, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F, Praloran V, Dupriez B, Demory JL, Jasmin C, Martyré M-C: Differential expression of transforming growth factor-β, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88:4534, 1996.
46. Williams GT, Smith CA, Spooner E, Dexter TM, Taylor DR: Hematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79, 1990.
47. Zouali M, Kalsi J, Isenberg D: Autoimmune diseases - at the molecular level. Immunol Today 14:473-476, 1993.
48. Cerwenka A, Kovar H, Majdic O, Holter W: Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-β1. J Immunol 156:459-464, 1996.
49. Rosenfeld CS. Transforming growth factor-β1 augments macrophage-colony stimulating factor activity on human marrow. Stem Cells 12: 527-532, 1994.
50. Calafat, J, Janssen H, Stähle-Bäckdahl M, Zuurbier AEM, Knol EF, Egesten A: Human monocytes and neutrophils store transforming growth factor-α in a subpopulation of cytoplasmic granules. Blood 90:1255-1266, 1997.
51. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL: Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81:631-638, 1993.
52. Johnston JB, Dalal BI, Isreaels SJ, Oh S, McMillan E, Begleiter A, Michaud G, Isreaels LG, Greenberg AH: Deposition of transforming growth factor-β in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-β by leukemic cells. Am J Clin Pathol 103:574-582, 1995.
53. Martyré M-C, Le Bousse-Kerdiles M-C, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B: Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97:441-448, 1997.
54. Ivanovic V, Melman A, Davis-Joseph B, Valcic M, Geliebter J: Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nature Med 1:282-284, 1995.
55. Border WA, Noble NA: Targeting TGF-β for treatment of disease. Nature Med 1:1000-1001, 1995.
56. Villeval, JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein S, Cramer EM, Vainchenker W, Wendung F: Dysregulated Mpl-ligand production by hemopoietic cells induces a fatal myeloproliferative syndrome in mice. Hematol Cell Ther 39:117, 1997.